Scientists and administrators across campus are putting finishing touches on an application due Oct. 14 for a Clinical and Translational Science Award (CTSA) from the National Center for Research Resources (NCRR), part of the National Institutes of Health (NIH).
CTSA awards, with budgets of $20 million over five years, are intended to dramatically spur translational and clinical research, overcoming the barrier that exists between basic science and the ability to move discoveries to patients’ bedside or other clinical settings. Competition for these awards is intense. Forty-six CTSA applications have been funded since 2006, with plans to confer a total of 60 awards nationally; in addition, some of the funded awards are coming up for competitive renewals. Roughly half of the nation’s 130 medical schools will have a CTSA, and UB aspires to be part of this elite grouping. It would position the university as part of a national consortium, spurring collaboration with other institutions and leveraging more funding to expand UB’s clinical research capabilities.